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Abstract
Objectives: This study aimed to compare pancreaticojejunostomy (PJ) with pancreaticogastrostomy
(PG) after pancreaticoduodenectomy (PD).
Methods: A literature search of PubMed and the Cochrane Central Register of Controlled Trials for
studies comparing PJ with PG after PD was conducted. The primary outcome for meta-analysis was
pancreatic fistula. Secondary outcomes were morbidity, mortality, biliary fistula, intra-abdominal fluid
collection, hospital length of stay (LoS), postoperative haemorrhage and reoperation. Outcome measures
were odds ratios (ORs) and mean differences with 95% confidence intervals (CIs).
Results: Seven recent RCTs encompassing 1121 patients (559 PJ and 562 PG cases) were involved in
this meta-analysis. Incidences of pancreatic fistula (10.6% versus 18.5%; OR 0.52, 95% CI 0.37–0.74;
P = 0.0002), biliary fistula (2.3% versus 5.7%; OR 0.42, 95% CI 0.03–3.15; P = 0.03) and intra-abdominal
fluid collection (8.0% versus 14.7%; OR 0.50, 95% CI 0.34–0.74; P = 0.0005) were significantly lower in
the PG than the PJ group, as was hospital LoS (weighted mean difference: −1.85, 95% CI −3.23 to −0.47;
P = 0.008). Subgroup analysis indicated that severe pancreatic fistula (grades B or C) occurred less
frequently in the PG than the PJ group (8.3% versus 20.5%; OR 0.37, 95% CI 0.23–0.59; P < 0.00001).
However, there was no significant difference in morbidity (48.9% versus 51.0%; OR 0.90, 95% CI
0.70–1.16; P = 0.41), mortality (3.2% versus 3.5%; OR 0.82, 95% CI 0.43–1.58; P = 0.56), delayed gastric
emptying (16.6% versus 14.7%; relative risk: 1.02, 95% CI 0.62–1.68; P = 0.94), postoperative haemor-
rhage (9.6% versus 11.1%; OR 0.82, 95% CI 0.54–1.24; P = 0.35) or reoperation (9.9% versus 9.8%; OR
0.93, 95% CI 0.60–1.43; P = 0.73).
Conclusions: Pancreaticogastrostomy provides benefits over PJ after PD, including in the incidences of
pancreatic fistula, biliary fistula and intra-abdominal fluid collection and in hospital LoS. Therefore, PG is
recommended as a safer and more reasonable alternative to PJ reconstruction after PD.
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Introduction
Pancreaticoduodenectomy (PD) is a standard surgical treatment
for patients with malignant or benign disease of the pancreatic
head and the periampullary region. There has been an obvious
decline in perimortality rates (to <5%) after PD carried out at
high-volume institutions and PD may perhaps represent the most
striking accomplishment in pancreatic surgery to date.1,2 However,
rates of surgical morbidity lie at 40–50% in many large specialized
centres.3–5 The development of a postoperative pancreatic fistula*These authors contributed equally to this paper.
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remains the main factor influencing morbidity and even morta-
lity.6,7 Therefore, pancreatic anastomotic leak following PD
remains an obstacle for surgeons and intensive medicine special-
ists. In the context of such challenging circumstances, many tech-
niques have been proposed to guarantee continuity between
the pancreatic remnant and the digestive tract.8–10 However, the
issue of which technique is optimal to restore pancreatic digestive
continuity remains controversial.
Four prospective randomized controlled trials (RCTs) and
three meta-analyses have demonstrated similar rates of pancre-
atic fistula in pancreaticojejunostomy (PJ) and pancreati-
cogastrostomy (PG) after PD.11–17 However, three recent RCTs
reported lower rates of pancreatic fistula in association with PG
(3.8%, 15.3% and 8.0%, respectively) than PJ (18.2%, 34.5% and
19.8%, respectively).18–20 Almost all retrospective studies compa-
ring PG and PJ have suggested that the rate of pancreatic fistula is
reduced in PG. These recent RCTs and retrospective studies may
suggest that PG is more efficient than PJ in reducing the incidence
of pancreatic fistula after PD.11 Hence, in order to evaluate and
compare the results of PG and PJ after PD, a meta-analysis of
RCTs published between 1992 and 2013 was performed. The
primary outcome of interest was the rate of pancreatic fistula.
Materials and methods
Literature search
A thorough literature search was performed using PubMed
and the Cochrane Central Register of Controlled Trials for poten-
tially relevant RCTs comparing outcomes in, respectively, PJ
and PG, conducted between January 1992 and December
2013. The search was performed independently by two authors
(J-MC and WG) using the keywords: ‘pancreatogastrostomy’;
‘pancreaticogastrostomy’; ‘pancreaticogastric anastomosis’;
‘pancreatojejunostomy’; ‘pancreaticojejunostomy’; ‘pancreatijco-
jejunal anastomosis’; ‘pancreatoenteric anastomosis’; ‘pancreato-
duodenectomy’, and ‘pancreatoduodenal resection’. References
within the articles were also analysed for other relevant studies.
Inclusion and exclusion criteria
The goal of the meta-analysis was to evaluate surgical and func-
tional outcomes in cohorts of patients submitted to PJ or PG after
PD. Studies were required to meet the following criteria: (i) to be
published in English; (ii) to compare PJ with PG; (iii) to use an
RCT design; (iv) to report at least one outcome, and (v) to clearly
document the surgical procedure. If two studies were found to
overlap, the higher-quality publication was selected. Articles were
excluded if they failed to fulfil any of these criteria.
Data extraction and quality assessment
Once studies had been identified as qualifying for inclusion in
the meta-analysis, data extraction and critical appraisal were
undertaken independently by two authors (F-BL and WG). Any
disagreements were discussed and resolved by consensus.
The primary outcome measure was the occurrence of pancre-
atic fistula. Secondary outcomes were mortality, morbidity, occur-
rence of biliary fistula, occurrence of delayed gastric emptying,
occurrence of intra-abdominal collection, reoperation rate, occur-
rence of postoperative haemorrhage and hospital length of stay
(LoS).
Statistical analysis
All statistical analyses were carried out using RevMan Version 5.1
(Cochrane Collaboration, Oxford, UK). Continuous data (e.g.
hospital LoS) were analysed using the weighted mean difference
(WMD) or standard mean difference (SMD) with 95% confi-
dence intervals (CIs). Dichotomous data were analysed using the
odds ratio (OR) and a fixed-effects model.21 When significant
heterogeneity existed, data were analysed using a random-effects
model.22 Heterogeneity was evaluated using the chi-squared test,
in which a P-value of <0.1 was considered significant. Differences
resulting in a P-value of <0.05 were considered statistically signifi-
cant. Risk for bias was evaluated using a funnel plot. The quality of
all studies was evaluated using the scoring systems of Jadad et al.23
and Chalmers et al.24
Results
Results of the search
The literature search strategy and trial selection are shown in
Fig. 1. In total, seven RCTs14–20 were selected for inclusion in this
meta-analysis. A total of 1121 patients had been randomized to
either PJ (559 patients) or PG (562 patients). The sample sizes of
trials ranged from 116 to 329. The main characteristics of the
seven RCTs are shown in Tables 1 and 2. Patient characteristics
and preoperative parameters were similar in the two groups.
According to Jadad et al.23 and Chalmers et al.,24 two of the trials
included were of low quality as a result of their use of inadequate
randomization methods and an absence of blinding, power cal-
culations and intention-to-treat analysis. Five trials were scored as
being of moderate strength as a result of their use of relatively
good randomization techniques and the presence of blinding,
power calculations and intention-to-treat analysis.
Definitions of pancreatic fistula and its severity were extracted
from the International Study Group on Pancreatic Fistula (ISGPF)
in four RCTs.17–20 The other three RCTs applied centre-specific
definitions of pancreatic fistula.14–16 Based on ISGPF criteria, pan-
creatic fistula was defined according to an increased level of
amylase in the effluent drain three times higher than the normal
serum amylase level. These data were further classified to indicate
fistula of grade A (transient, without clinical impact), grade B
(abnormal laboratory parameters with a non-invasive change in
therapeutic management), and grade C (abnormal laboratory
parameters that require invasive treatment and are associated with
sepsis or death), respectively.25
Biliary fistula was diagnosed according to bilirubin containing
discharge in a distinctive colour or fistulography.14,15,18
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Risk for publication bias
A funnel plot analysis (Fig. 2) was applied to assess the possibility
of publication bias; findings showed a non-significant likelihood.
Primary outcome
The meta-analysis of the primary outcome investigated the occur-
rence of pancreatic fistula in all of the included RCTs (14.5%). The
raw incidence of pancreatic fistula was significantly lower in the
PG than the PJ group (10.6% versus 18.5%; OR 0.52, 95% CI
0.37–0.74; P = 0.0002) (Fig. 3). Subgroup analysis indicated that
severe pancreatic fistula defined according to the international
consensus definition (grades B or C) was less likely to occur in
association with PG than PJ (8.3% versus 20.5%; OR 0.37, 95% CI
0.23–0.59; P < 0.00001) (Fig. 3).
Secondary outcomes
Morbidity
Six trials provided specific information about total compli-
cations.14–19 There was no significant heterogeneity among these
trials (I2 = 30%; P = 0.21). Meta-analysis showed that the level of
risk for the development of any postoperative complication was
statistically similar in both groups (48.9% versus 51.0%; OR 0.90,
95% CI 0.70–1.16; P = 0.41) (Fig. 4).
Mortality
Mortality was compared across all studies.14–20 Mortality rates in
the PG and PJ groups were 3.2% (18 of 562 patients) and 3.6% (20
of 559 patients), respectively. There was no significant difference
in mortality between the two groups (OR 0.82, 95% CI 0.43–1.58;
P = 0.56). There was no evidence of heterogeneity among studies
(I2 = 0%; P = 0.84).
Biliary fistula
Five articles covering a total of 676 patients reported data on the
occurrence of biliary fistula (4.0%).14–18 The occurrence of biliary
fistula was significantly reduced in the PG group in comparison
with the PJ group (2.3% versus 5.7%; OR 0.42, 95% CI 0.03–3.15;
P = 0.03) (Fig. 5). There was no statistical heterogeneity among
these studies (I2 = 46%; P = 0.11).
Intra-abdominal fluid collection
All trials provided specific information on the occurrence of
intra-abdominal fluid collection.14–20 There was no heterogeneity
among the trials (I2 = 38%; P = 0.14). In the fixed-effects model
(OR 0.50, 95% CI 0.34–0.74; P = 0.0005) (Fig. 6), the risk for
intra-abdominal fluid collection was lower in the PG than the PJ
group (8.0% versus 14.7%).
Delayed gastric emptying
Six studies reported delayed gastric emptying.14,16–20 Meta-analysis
indicated there was no significant difference in delayed gastric
emptying between the PG and PJ groups (random-effects model,
16.6% versus 14.7%; relative risk 1.02, 95% CI 0.62–1.68;
P = 0.94), but there was evidence of significant heterogeneity
(I2 = 58%; P = 0.03).
Postoperative haemorrhage
Six studies compared PG with PJ for the occurrence of postopera-
tive haemorrhage.14,15,17–20 Using a fixed-effects model, the pooled
data showed there was no significant difference in postoperative
bleeding between the two groups (9.6% versus 11.1%; OR 0.82,
95% CI 0.54–1.24; P = 0.35), and no significant heterogeneity
(I2 = 0%; P = 0.60).
Reoperation
Reoperation was analysed in five studies.14,15,17,19,20 Rates of reope-
ration in the PG and PJ groups were 9.9% and 9.8%, respec-
tively, and thus showed no significant difference (OR 0.93, 95%
CI 0.60–1.43; P = 0.73). No heterogeneity was found (I2 = 0%;
P = 0.82).
Length of hospital stay
All studies reported the hospital LoS. However, data from
four studies were excluded because information on the standard
deviation was lacking.15,18–20 The hospital LoS was significantly
Potentially relevant studies identified and
screened for retrieval (n = 145)
Studies excluded after reviewing of
titles and abstracts (n = 134)
  Irrelevant to PG and PJ (n = 63)
  Non-randomized (n = 34)
  Review (n = 11)
  Meta-analysis (n = 7)
  Non-English (n = 16)
Potentially appropriate RCTs screened for
more detailed review (n = 11)
Studies excluded after detail
screening (n = 4)
  Not real RCTs (n = 3)
  Duplicate publication data (n = 1)
Studies ultimately included in meta-analysis
(n = 7)
Figure 1 Flowchart of literature search. RCT, randomized controlled
trial
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shorter in the PG than the PJ group (random-effects model,
WMD −1.85, 95% CI −3.23 to −0.47; P = 0.008). However, signifi-
cant heterogeneity was apparent among these studies (I2 = 95%;
P < 0.00001).
Discussion
Since the first successful PD was performed by Kausch in 1909 and
its description published in 1912,26 the best technique for pancre-
atic anastomosis has remained controversial.27 This meta-analysis
of seven RCTs allowed for an analysis of pooled data
for PG and PJ, respectively, after PD. The pooled results showed
that PG represents a better option than PJ after PD by comparing
the occurrences of pancreatic fistula, biliary fistula and intra-
abdominal fluid collection, and hospital LoS. However, no differ-
ences between the groups emerged in morbidity, mortality,
delayed gastric emptying, postoperative haemorrhage and
reoperation.
Table 1 Characteristics of seven randomized controlled trials comparing outcomes of pancreaticogastrostomy (PG) and pancreaticoje-
junostomy (PJ) after pancreaticoduodenectomy
Study Sample
size
Male
patients, n
Age, years,
mean ± SD
Soft
parenchyma, %
PPPD, % Setting
Bassi et al. (2005)14 PG 69 44 59.3 100% 95.7% Single centre
PJ 82 51 55.5 100% 85.4%
Duffas et al. (2005)15 PG 81 51 58.2 ± 11 60.5% 22% Multicentre
PJ 68 35 58.6 ± 12 60.3% 26%
Fernandez-Cruz et al. (2008)17 PG 53 29 63 ± 13 45.3% 100% Single centre
PJ 55 38 63 ± 14 45.5% 100%
Figueras et al. (2013)18 PG 65 44 67 52.3% 46.2% Two centres
PJ 58 37 65.5 56.9% 48.3%
Topal et al. (2013)19 PG 162 100 67.0 – 60.5% Multicentre
PJ 167 91 66.1 – 61.1%
Wellner et al. (2012)20 PG 59 27 67 59.3% 88.1% Single centre
PJ 57 29 64 50.8% 94.5%
Yeo et al. (1995)16 PG 73 33 61.5 ± 1.7 21.9% 82.2% Single centre
PJ 72 40 62.4 ± 1.4 23.6% 81.9%
SD, standard deviation; PPPD, pylorus-preserving pancreaticoduodenectomy.
Table 2 Characteristics of seven randomized controlled trials comparing outcomes of pancreaticogastrostomy (PG) and pancreaticoje-
junostomy (PJ) after pancreaticoduodenectomy
Study Sample
size, n
Patients with diseases, n Surgical techniques
PDAC DD Amp DBD Others
Bassi et al. (2005)14 PG 69 32 1 13 1 22 Single-layer non-absorbable interrupted stitches
PJ 82 28 1 11 2 40 Single-layer duct to mucosa or side-to-side
Duffas et al. (2005)15 PG 81 34 3 17 8 19 Not described
PJ 68 25 3 19 11 10 End-to-end or end to side
Fernandez-Cruz et al. (2008)17 PG 53 26 1 12 8 6 Duct-to-mucosa with gastric partition
PJ 55 28 1 10 7 9 End-to-side duct mucosa
Figueras et al. (2013)18 PG 65 33 6 8 8 10 Two-layer invagination
PJ 58 29 10 7 3 9 Duct-to-mucosa
Topal et al. (2013)19 PG 162 98 11 23 28 2 End-to-side telescope
PJ 167 107 14 28 15 3 End-to-side telescope
Wellner et al. (2012)20 PG 59 26 3 9 2 19 Invagination
PJ 57 30 2 7 2 16 Duct-to-mucosa
Yeo et al. (1995)16 PG 73 40 4 7 6 16 Two-layer, end-to-end
PJ 72 40 5 11 7 9 Two-layer, end-to-end or end-to-side
PDAC, pancreatic ductal adenocarcinoma; DD, duodenal carcinoma; Amp, ampullary carcinoma; DBD, distal bile duct cancer; PG,
pancreaticogastrostomy; PJ, pancreaticojejunostomy.
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Pancreatic fistula is the most important postoperative compli-
cation and is at times fatal; it may also play a central role in
the development of other intra-abdominal complications, such as
haemorrhage and leak.4,7,28 Pancreatic surgeons are generally
agreed that pancreatic fistula represents the ‘Achilles heel’ of PD.29
Unlike previous meta-analyses of RCTs,11–13,30 the present pooled
analysis of data pertaining to the occurrence of pancreatic fistula
demonstrated that it is significantly lower in PG than in PJ (10.6%
versus 18.5%; OR 0.52, 95% CI 0.37–0.74; P = 0.0002) after PD.
Definitions of pancreatic fistula varied until 2005, when the
ISGPF presented a unified definition and system of grading sever-
ity. The unified definitions have enabled the consistent compari-
son of treatment outcomes after pancreatic surgery.25 All of the
previous three RCTs and meta-analyses employed different defi-
nitions of pancreatic fistula, which has limited their
comparability.11–16,30,31 The Verona centre-specific definition of
pancreatic fistula required confirmation by fistulography, but
fistulography is neither mandatory nor recommended in the
current International Study Group of Pancreatic Surgery (ISGPS)
criteria.14 The Baltimore centre definition of pancreatic fistula
referred to drainage of >50 ml of amylase-rich fluid after postop-
erative day 10 or to the disruption of pancreatic anastomosis
demonstrated radiographically, which may underestimate the
overall occurrence of postoperative pancreatic fistula in compari-
son with the ISGPF definition.16 A relatively high rate of mortality
(11%) calls into question experiences with both forms of pancre-
atic reconstruction in an RCT conducted in France.15
Four RCTs used the international consensus definition.17–20 The
present subgroup analysis indicated that in the later four RCTs,
severe pancreatic fistula (of grade B or C) according to the inter-
national consensus occurred less often in the context of PG than
PJ (8.3% versus 20.5%; OR 0.37, 95% CI 0.23–0.59; P < 0.00001).
Occurrences of pancreatic fistula according to centre-specific defi-
nitions in the other three RCTs showed no significant difference
between the two groups (14.0% versus 15.8%; OR 0.85, 95% CI
0.50–1.44; P = 0.54). A recent nationwide, large-scale, multicentre
randomized superiority trial showed that PG resulted in a lower
incidence of clinically relevant pancreatic fistula than PJ (8.0%
versus 19.8%), irrespective of the diameter of the pancreatic
duct.19
Many other factors can lead to pancreatic fistula, including
disease factors (pancreatic texture, pancreatic pathology, pancre-
atic duct size, pancreatic juice output), patient-related factors
(age, sex, jaundice, comorbid illness, previous gastric surgery),
surgeon-related factors (familiarity) and operative factors (opera-
tion time, type of anastomosis, stenting of pancreatic duct).7,32–34
The method of anastomosis after PD should be selected according
to all of these factors. In the discussion of PG versus PJ, it would be
preferable to know which method of construction of anastomosis
will be better among the end-to-side, dunking, invagination of the
pancreas and duct-to-mucosa techniques. However, the meta-
analysis of these seven RCTs did not support any conclusions on
which technique is optimal in terms of preventing the occurrence
of complications.14–20 Details of anastomosis methods used in the
seven RCTs are shown in Table 2. Berger et al. reported an RCT in
which the authors found that end-to-side invagination PJ in the
soft pancreas was associated with a significantly lower rate of
pancreatic fistula than duct-to-mucosa PJ in hard pancreas.8 By
contrast, Bassi et al. found no statistically significant difference
between duct-to-mucosa and one-layer end-to-side invagination
anastomosis in pancreatic fistula after PD.35 Therefore, further
adequately powered and well-designed RCTs are necessary to
establish whether anastomosis to the stomach or the jejunum is
preferable in reducing pancreatic anastomotic failure, and to
ascertain which specific type of anastomosis is superior.
Previous meta-analyses of observational clinical studies have
demonstrated a significantly lower incidence of biliary fistula in
PG in comparison with PJ. Similarly, the present meta-analysis
showed that biliary fistula was significantly higher in PJ than PG.
Although the difference was significant, the present findings
should be interpreted with caution. Bassi et al. concluded that a
significantly lower incidence of biliary fistula was associated with
PG.35 The difference may be mainly associated with the presence
in a nearby area of a double anastomosis (jejunal-pancreatic and
biliary) in PJ rather than a single biliary anastomosis in PG, which
was confirmed by the observation that 42.9% of patients with
biliary fistula also had concomitant pancreatic fistula. However,
the other four RCTs showed there to be no statistically significant
difference between PG and PJ in the occurrence of biliary fistula.
Moreover, the average incidence of biliary fistula was only 4.0%
and thus biliary fistula was rare with any reconstruction type
across all RCTs. Therefore, it seems that further randomized trials
are needed to assess the true impact of PG on biliary fistula.
The technique of PG has several theoretical physiolo-
gical and technical advantages over PJ. Firstly, a physiological
Centre-specific definition International consensus
 definition
Subgroups
0 SE(log[OR])
OR
0.2
0.4
0.6
0.8
1
0.01 0.1 1 10 100
Figure 2 Funnel plot analysis showing no publication bias for the
occurrence of pancreatic fistula. SE, standard error; OR, odds ratio
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advantage is believed to derive from the fact that exocrine
pancreatic secretions are easily activated in the presence of intes-
tinal enterokinase and bile, but not in the acidic gastric environ-
ment. Secondly, the excellent blood supply to the stomach wall
is favourable to anastomotic healing and the thickness of the
stomach wall holds sutures well. Thirdly, PG avoids the long
jejunal loop, which may impose tension on the anastomosis as
a result of the accumulation of pancreaticobiliary secretions
and the weight of the loop itself. Fourthly, routine nasogastric
decompression facilitates the continuous removal of pancreatic
and gastric secretions, which may decrease any tension on the
anastomosis. The present meta-analysis has demonstrated the
superiority of PG over PJ in terms of pancreatic fistula, biliary
fistula, intra-abdominal fluid collection and hospital LoS, the
last of which may derive from the aforementioned theoretical
advantages.
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PG PJ Odds Ratio
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Figure 3 Comparison of pancreaticogastrostomy (PG) and pancreaticojejunostomy (PJ) in terms of pancreatic fistula. 95% CI, 95%
confidence interval; M-H, Mantel–Haenszel method
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Figure 4 Comparison of pancreaticogastrostomy (PG) and pancreaticojejunostomy (PJ) in terms of morbidity. 95% CI, 95% confidence
interval; M-H, Mantel–Haenszel method
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However, there are several limitations to the present review.
Firstly, although no detectable publication bias was found on
funnel plotting, all trials had a high risk for bias caused by lack of
blinding. The definitions of pancreatic fistula varied among RCTs,
three of which used centre-specific definitions. Moreover, the
methods of pancreatic anastomosis were themselves hetero-
geneous and involved different techniques (duct-to-mucosa,
invagination, single-layer and two-layer methods) and different
types of suture. Different methods of anastomosis may lead to
different complications. Additionally, because it was not possible
to perform subgroup analyses according to pancreatic duct size,
pancreatic texture or pancreatic pathology, it is unclear whether
the potential advantages of PG are applicable to all subgroups of
patients. The heterogeneity among studies in terms of surgeon
experience is unavoidable. Finally, none of the studies described
longterm postoperative mortality and morbidity, which are
crucial to any assessment of the curative effects of PG and PJ.
In summary, the results of this meta-analysis showed that PG is
more efficient than PJ in reducing incidences of pancreatic fistula,
biliary fistula and intra-abdominal fluid collection, and hospital
LoS. Rates of morbidity, mortality, delayed gastric emptying, post-
operative haemorrhage and reoperation were comparable between
the two groups. Further adequately powered and well-designed
RCTs are required to verify these results and to confirm whether
these results apply to an equal extent in all patient subgroups.
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